Skip to main content
. 2017 Nov 20;8(62):106026–106037. doi: 10.18632/oncotarget.22523

Figure 5. RTL1/β-Catenin engages in tumour growth in vivo.

Figure 5

(A) The tumour growth curve was obtained from RTL1-overexpressing (RTL1-OE) and control (FUGW) cells; (B) the tumour growth curve was obtained from RTL1-knockdown (shRTL1) and control (Scramble) cells; (C) images of tumours obtained from RTL1-overexpressing cells and the statistical analysis of tumour weight; (D) images of tumours obtained from RTL1-knockdown cells and the statistical analysis of the tumour weight. Compared to FUGW or Scramble, ** p<0.01 and *** p<0.001; (E) the immunohistochemical assay for the expression level of RTL1, β-CATENIN, c-MYC and CYCLIN D1 in tumour tissues.